Discover the latest French guidelines on the crucial screening for precancerous anal lesions associated with human papillomaviruses, and learn how these recommendations are shaping the fight against HPV-related cancers.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practice.
Spindler et al., Tech Coloproctol 2024
DOI: 10.1007/s10151-023-02899-8
Summary of Anal Cancer Screening in France
New Information: The abstract provides a detailed overview of the high-risk groups for anal cancer in France, the importance of screening for high-grade squamous intraepithelial lesions (HSILs), and the effectiveness of various screening methods.
Importance: This information is crucial for early detection and treatment of anal cancer, which is often preceded by HSILs and is linked to HPV16 infection.
Contribution to Literature: The abstract highlights the sensitivity of anal cytology in detecting HSILs, with a sensitivity greater than 80%, and the superior performance of high-resolution anoscopy compared to standard proctological examination with anoscopy. It also notes the limited availability of high-resolution anoscopy and calls for the development of this technique and triage tests, as well as the evaluation of screening strategies.
For symptomatic patients, a proctological examination with standard anoscopy is recommended. Asymptomatic high-risk patients should initially be tested for HPV16 to identify those at risk of HSILs. If the HPV16 test is positive, anal cytology is indicated. In cases of cytological abnormalities or clinical suspicion of dysplasia, high-resolution anoscopy is advised, if available. Otherwise, standard proctological examination is the alternative.